XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private...

XTL Entered Definitive Agreement to Acquire The Social Proxy expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million...

XTL To Aquire The Social Proxy expands its IP portfolio to AI Web Data The Social Proxy is a web data AI companydeveloping and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a...

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets...

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets...